Glucose Medipharm (Glucose Monohydrate)

Glucose Medipharm is employed in healthcare facilities as an intravenous carbohydrate source. It provides readily available energy and contributes to fluid balance during various medical procedures.

• Energy supplementation for patients requiring caloric support during fasting or surgery.
• Maintenance of blood glucose levels in individuals with hypoglycemia or metabolic needs.
• Dilution and carrier solution for compatible intravenous medications.
• Support of electrolyte balance when combined with appropriate electrolyte formulations.
• Volume replacement in patients needing isotonic fluid administration.

Intravenous administration of Glucose Medipharm may be associated with a range of physiological responses. While many reactions are mild and transient, more serious events can occur in susceptible individuals.

Common

• Transient hyperglycemia leading to temporary elevation of blood glucose.
• Mild infusion site irritation or erythema.
• Nausea or mild gastrointestinal discomfort.
• Headache or light‑headedness during rapid infusion.

Serious

• Severe hyperglycemia with risk of osmotic diuresis.
• Allergic reactions such as urticaria, rash, or anaphylaxis.
• Electrolyte disturbances, particularly hyponatremia when used in large volumes.
• Fluid overload resulting in pulmonary edema in patients with compromised cardiac function.

When using Glucose Medipharm, clinicians should observe specific precautions to minimize risks and ensure patient safety.

• Assess baseline blood glucose and monitor levels regularly during infusion.
• Adjust infusion rate in patients with diabetes or impaired glucose tolerance.
• Evaluate cardiac and renal function before large‑volume administration.
• Avoid use in individuals with known hypersensitivity to glucose preparations.
• Ensure compatibility with other intravenous drugs to prevent precipitation.
• Use aseptic technique to maintain sterility of the solution.

Glucose Medipharm can interact with certain medications or clinical conditions, influencing its safety and efficacy.

Avoid

• Concurrent high‑dose insulin therapy without appropriate glucose monitoring.
• Co‑administration with potassium chloride solutions that may cause precipitation.
• Use with hyperosmolar agents that increase risk of hyperglycemia.

Use with caution

• Concurrent diuretics that may alter fluid and electrolyte balance.
• Administration alongside catecholamines that can affect glucose metabolism.
• Patients receiving total parenteral nutrition where glucose load must be carefully calculated.